Retrieve available abstracts of 35 articles: HTML format
Single Articles
December 2025
KEDHI E, Hermanides RS, Dambrink JE, Singh SK, et al TransCatheter aortic valve implantation and fractional flow reserve-guided
percutaneous coronary intervention versus conventional surgical aortic valve
replacement and coronary bypass grafting for treatment of patients with aortic
valve stenosis and c
Lancet. 2025;404:2593-2602. PubMedAbstract available
March 2025
CHOI KH, Park YH, Lee JY, Jeong JO, et al Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high
risk of subsequent cardiovascular event after percutaneous coronary intervention
(SMART-CHOICE 3): a randomised, open-label, multicentre trial.
Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449. PubMedAbstract available
KIRTANE AJ, Genereux P, Lewis B, Shlofmitz RA, et al Orbital atherectomy versus balloon angioplasty before drug-eluting stent
implantation in severely calcified lesions eligible for both treatment strategies
(ECLIPSE): a multicentre, open-label, randomised trial.
Lancet. 2025 Mar 28:S0140-6736(25)00450-7. doi: 10.1016/S0140-6736(25)00450. PubMedAbstract available
FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al Outcomes after fractional flow reserve-guided percutaneous coronary intervention
versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a
multicentre, open-label, randomised trial.
Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505. PubMedAbstract available
HU X, Zhang J, Yang S, Jiang J, et al Angiography-derived fractional flow reserve versus intravascular ultrasound to
guide percutaneous coronary intervention in patients with coronary artery disease
(FLAVOUR II): a multicentre, randomised, non-inferiority trial.
Lancet. 2025 Mar 28:S0140-6736(25)00504-5. doi: 10.1016/S0140-6736(25)00504. PubMedAbstract available
February 2025
HILL MD, Goyal M, Demchuk AM, Menon BK, et al Efficacy and safety of nerinetide in acute ischaemic stroke in patients
undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT):
a multicentre, double-blind, randomised controlled trial.
Lancet. 2025;405:560-570. PubMedAbstract available
LI W, Lan J, Wei M, Liu L, et al Normobaric hyperoxia combined with endovascular treatment for acute ischaemic
stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind,
sham-controlled trial.
Lancet. 2025;405:486-497. PubMedAbstract available
December 2024
NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic
review and individual patient data meta-analysis.
Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820. PubMedAbstract available
November 2024
LIU J, Zhou Y, Zhang L, Li Z, et al Balloon guide catheters for endovascular thrombectomy in patients with acute
ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a
multicentre, open-label, blinded-endpoint, randomised controlled trial.
Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315. PubMedAbstract available
October 2024
ANDERSEN BK, Sejr-Hansen M, Maillard L, Campo G, et al Quantitative flow ratio versus fractional flow reserve for coronary
revascularisation guidance (FAVOR III Europe): a multicentre, randomised,
non-inferiority trial.
Lancet. 2024 Oct 29:S0140-6736(24)02175-5. doi: 10.1016/S0140-6736(24)02175. PubMedAbstract available
ERLINGE D, Andersson J, Frobert O, Tornerud M, et al Bioadaptor implant versus contemporary drug-eluting stent in percutaneous
coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind,
non-inferiority, registry-based, randomised controlled trial.
Lancet. 2024 Oct 25:S0140-6736(24)02227-X. doi: 10.1016/S0140-6736(24)02227. PubMedAbstract available
September 2024
NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al Endovascular management of acute stroke.
Lancet. 2024;404:1265-1278. PubMedAbstract available
August 2024
VALGIMIGLI M, Hong SJ, Gragnano F, Chalkou K, et al De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet
therapy in patients with and without acute coronary syndromes: a systematic
review and individual patient-level meta-analysis of randomised trials.
Lancet. 2024 Aug 30:S0140-6736(24)01616-7. doi: 10.1016/S0140-6736(24)01616. PubMedAbstract available
HONG SJ, Lee SJ, Lee SH, Lee JY, et al Optical coherence tomography-guided versus angiography-guided percutaneous
coronary intervention for patients with complex lesions (OCCUPI): an
investigator-initiated, multicentre, randomised, open-label, superiority trial in
South Korea.
Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454. PubMedAbstract available
MAMAS MA, Mintz GS Optical coherence tomography imaging for complex percutaneous coronary
intervention.
Lancet. 2024 Aug 30:S0140-6736(24)01593-9. doi: 10.1016/S0140-6736(24)01593. PubMed
GAO C, He X, Ouyang F, Zhang Z, et al Drug-coated balloon angioplasty with rescue stenting versus intended stenting for
the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I):
an open-label, randomised, non-inferiority trial.
Lancet. 2024 Aug 30:S0140-6736(24)01594-0. doi: 10.1016/S0140-6736(24)01594. PubMedAbstract available
MCENTEGART MB, Kirtane AJ How feasible is a cage-free solution for de novo coronary artery disease?
Lancet. 2024 Aug 30:S0140-6736(24)01696-9. doi: 10.1016/S0140-6736(24)01696. PubMed
May 2024
HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al Stroke.
Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642. PubMedAbstract available
April 2024
FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader FA, et al Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a
randomised, placebo-controlled trial.
Lancet. 2024;403:1543-1553. PubMedAbstract available
LI X, Ge Z, Kan J, Anjum M, et al Intravascular ultrasound-guided versus angiography-guided percutaneous coronary
intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre,
randomised trial.
Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282. PubMedAbstract available
DEN DEKKER WK Is intravascular imaging the future of percutaneous coronary intervention?
Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430. PubMed
GE Z, Kan J, Gao X, Raza A, et al Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after
percutaneous coronary intervention in patients with acute coronary syndromes
(ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473. PubMedAbstract available
PARK SJ, Ahn JM, Kang DY, Yun SC, et al Preventive percutaneous coronary intervention versus optimal medical therapy
alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT):
a multicentre, open-label, randomised controlled trial.
Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413. PubMedAbstract available
BOROVAC JA Percutaneous coronary intervention for non-obstructive vulnerable plaques.
Lancet. 2024 Apr 4:S0140-6736(24)00488-4. doi: 10.1016/S0140-6736(24)00488. PubMed
February 2024
LEE ZS, Ryan N Intravascular imaging in percutaneous coronary intervention.
Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686. PubMed
STONE GW, Christiansen EH, Ali ZA, Andreasen LN, et al Intravascular imaging-guided coronary drug-eluting stent implantation: an updated
network meta-analysis.
Lancet. 2024 Feb 21:S0140-6736(23)02454-6. doi: 10.1016/S0140-6736(23)02454. PubMedAbstract available
CONSOLI A, Gory B Long-term results of mechanical thrombectomy for large ischaemic stroke.
Lancet. 2024 Feb 8:S0140-6736(24)00158-2. doi: 10.1016/S0140-6736(24)00158. PubMed
SARRAJ A, Abraham MG, Hassan AE, Blackburn S, et al Endovascular thrombectomy plus medical care versus medical care alone for large
ischaemic stroke: 1-year outcomes of the SELECT2 trial.
Lancet. 2024 Feb 8:S0140-6736(24)00050-3. doi: 10.1016/S0140-6736(24)00050. PubMedAbstract available
January 2024
LANDI A, Pedrazzini G, Wild L, Beele A, et al Coronary embolisation of native aortic valve debris during transcatheter aortic
valve replacement: mechanical embolectomy and histopathological analysis.
Lancet. 2024;403:e5-e6. PubMed
December 2023
JIMENEZ DIAZ VA, Iniguez Romo A Intracoronary artery visualisation of crystalline sirolimus deposits after
drug-coated balloon angioplasty for acute coronary syndrome.
Lancet. 2023;402:2111-2112. PubMed
October 2023
IGLESIAS JF, Roffi M, Losdat S, Muller O, et al Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus
durable polymer everolimus-eluting stents in ST-segment elevation myocardial
infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.
Lancet. 2023 Oct 25:S0140-6736(23)02197-9. doi: 10.1016/S0140-6736(23)02197. PubMedAbstract available
BUITEN RA, Ploumen EH Drug-eluting stents for ST-segment elevation myocardial infarction: extending the
biodegradable versus durable polymer debate.
Lancet. 2023 Oct 25:S0140-6736(23)02297-3. doi: 10.1016/S0140-6736(23)02297. PubMed
DIPPEL DWJ, Roozenbeek B Thrombectomy for acute ischaemic stroke without advanced imaging.
Lancet. 2023 Oct 10:S0140-6736(23)02229-8. doi: 10.1016/S0140-6736(23)02229. PubMed
BENDSZUS M, Fiehler J, Subtil F, Bonekamp S, et al Endovascular thrombectomy for acute ischaemic stroke with established large
infarct: multicentre, open-label, randomised trial.
Lancet. 2023 Oct 10:S0140-6736(23)02032-9. doi: 10.1016/S0140-6736(23)02032. PubMedAbstract available
August 2023
HANKEY GJ Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
Lancet. 2023 Aug 25:S0140-6736(23)01202-3. doi: 10.1016/S0140-6736(23)01202. PubMed